Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This study is being conducted to investigate risk factors for disability progression in Multiple Sclerosis and related disorders (MSRD). The primary goal is to assess whether combining information from visual assessment, blood markers, as well as historical and ongoing longitudinal MRIs of the brain, orbit (the part of the skull where eyes are located), and/or spinal cord can predict changes in quantitative disability measures related to MSRD and neurological disease.
Screening:
Prospective participants will be screened at Cedars-Sinai Medical Center (CSMC) through a comprehensive review of their medical and MRI records done as part of standard of care to determine if they are eligible to participate in this study. If they never had an MRI at CSMC, they will be asked to provide records of an MRI done at another site. If the study team determines that they are eligible to continue participating, then they will move on to the main research study.
Main Research Study:
The following items will be collected as part of the main research study:
Optional Sub-study:
Participants are not required to take part in the optional sub-study and can choose which sub-study procedures they would want to undergo. Participants can say no to the sub-study, and still remain in the main study. The optional sub-study involves undergoing one or more of the procedures below:
How long will participants be in the study? There is no prespecified end date for this study. Participants may remain in the main study as long as they are (1) willing to participate, (2) remain eligible for the study procedures, and (3) the study remains open.
Compensation for Participating Participants will be provided a voucher to cover parking expenses at Cedars-Sinai Medical Center during their participation in this research study if they undergo the optional sub-study procedures.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| RRMS, SPMS, PPMS, CIS or RIS | Multiple Sclerosis (relapsing-remitting, primary or secondary progressive forms), clinically isolated syndrome, or radiologically isolated syndrome | ||
| NMOSD | Neuromyelitis optica spectrum disorders | ||
| MOGAD | Myelin oligodendrocyte glycoprotein antibody disorders | ||
| Neurological disorder other than MSRD | Neurological disorders due to neurodegenerative, vascular, or headache conditions that are not related to multiple sclerosis or related disorders. | ||
| Healthy controls | Healthy controls with no known neurological conditions |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Identifying risk factors for disability progression | To investigate whether combining information from peripheral blood biomarkers, retinal structural, visual function, as well as historical and ongoing longitudinal MRIs (brain, cervical, and/or thoracic spinal cord) can predict quantitative disability progression risk | 10 years |
| Measure | Description | Time Frame |
|---|---|---|
| Effect of disease modifying therapy | Assess the effect modification of various Food and Drug Administration(FDA)-approved disease modifying therapy on disability risk | 10 years |
| Identify factors associated with visual disability and optic neuropathy in multiple sclerosis and related disorders |
Not provided
Inclusion Criteria:
Subjects who meet any one of the following diagnostic criteria:
Age ≥18.
Able to give informed consent.
Exclusion Criteria:
Not provided
Not provided
Not provided
Participants with the following conditions or healthy volunteers are eligible to participate in the study:
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Omar Al-Louzi, MD | Contact | (310) 423-4008 | omar.allouzi@cshs.org | |
| Group Neurology Research | Contact | (310)-423-6472 | GroupNeurologyMSProgramResearch@cshs.org |
| Name | Affiliation | Role |
|---|---|---|
| Omar Al-Louzi, MD | Cedars-Sinai Medical Center | Principal Investigator |
| Marwa Kaisey, MD | Cedars-Sinai Medical Center | Study Director |
| Brooke Guerrero, MD |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Cedars-Sinai Medical Center | Recruiting | Los Angeles | California | 90048 | United States |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 41841206 | Derived | Tayem AJ, Liu A, Manukyan S, Subhi M, Luskin E, Quah B, Nair SM, Has Silemek AC, Zabala G, Cui Y, Locke L, Barreras P, Kaisey M, Calsavara V, Reich DS, Sicotte NL, Sati P, Al-Louzi O. Paramagnetic Rim Lesions Are Associated With Trans-Synaptic Degeneration of the Visual Pathway in Multiple Sclerosis. Ann Clin Transl Neurol. 2026 Mar 17. doi: 10.1002/acn3.70352. Online ahead of print. |
| Label | URL |
|---|---|
| Cedars-Sinai Clinical Research Website | View source |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Using retinal structural and functional testing, this study will track longitudinal evolution of visual dysfunction and retinal injury |
| 10 years |
| Identify serum, genetic, and stem cell-derived biomarkers influencing disability risks | 10 years |
| Cedars-Sinai Medical Center |
| Study Director |
| Laura Locke, CRNP | Cedars-Sinai Medical Center | Study Director |
| Pascal Sati, PhD | Cedars-Sinai Medical Center | Study Director |
| Nancy Sicotte, MD | Cedars-Sinai Medical Center | Study Chair |
| ID | Term |
|---|---|
| D009103 | Multiple Sclerosis |
| D020529 | Multiple Sclerosis, Relapsing-Remitting |
| D020528 | Multiple Sclerosis, Chronic Progressive |
| D009471 | Neuromyelitis Optica |
| D000098542 | Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease |
| D020274 | Autoimmune Diseases of the Nervous System |
| D009422 | Nervous System Diseases |
| ID | Term |
|---|---|
| D020278 | Demyelinating Autoimmune Diseases, CNS |
| D003711 | Demyelinating Diseases |
| D001327 | Autoimmune Diseases |
| D007154 | Immune System Diseases |
| D002908 | Chronic Disease |
| D020969 | Disease Attributes |
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D009188 | Myelitis, Transverse |
| D009902 | Optic Neuritis |
| D009901 | Optic Nerve Diseases |
| D003389 | Cranial Nerve Diseases |
| D005128 | Eye Diseases |
Not provided
Not provided